A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Discussion Forum: Valeo Pharma Inc.
List Message View
Thread Message View
New Message
Author / Date /
Topic Title
Rating
Re
Last Post
AGORACOM - Apr 28, 2021 07:00AM
Icon agoracom Valeo Pharma's Redesca® and Redesca HP® to Be Covered Under the Ontario Public Drug Benefit Program

0
AGORACOM
Apr 28, 2021 07:00AM
AGORACOM - Apr 27, 2021 07:00AM
Icon agoracom Valeo Pharma Upsizes And Closes $6.6 Million Non-Brokered Private Placement

0
AGORACOM
Apr 27, 2021 07:00AM
AGORACOM - Apr 15, 2021 07:00AM
Icon agoracom Valeo Pharma Announces Commercial Launch of Redesca™ and Redesca HP™

0
AGORACOM
Apr 15, 2021 07:00AM
AGORACOM - Apr 14, 2021 07:00AM
Icon agoracom Valeo Pharma Announces $4.0 Million Non-Brokered Private Placement of Non-Convertible Debentures

0
AGORACOM
Apr 14, 2021 07:00AM
AGORACOM - Apr 06, 2021 07:00AM
Icon agoracom Valeo Pharma Completes Negotiations with Pan-Canadian Pharmaceutical Alliance for Redesca® and Redesca HP®

0
AGORACOM
Apr 06, 2021 07:00AM
AGORACOM - Jan 08, 2021 01:20PM
Icon agoracom AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) An Innovative Canadian Pharma Company With 9 Products Currently Marketed And 7 Products In Pipeline

1
lollp
Apr 05, 2021 07:06AM
AGORACOM - Dec 15, 2020 03:32PM
Icon agoracom AGORACOM Welcomes Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) With 7 Products To Be Launched In 2021 / 2022 ($45M. Estimated Peak Sales / Year)
1
1
lollp
Apr 05, 2021 05:51AM
AGORACOM - Apr 01, 2021 11:43AM
Icon agoracom AGORACOM Small Cap 60: What Gives Valeo Pharma A Competitive Advantage In The $700M Asthma Market?

0
AGORACOM
Apr 01, 2021 11:43AM
AGORACOM - Mar 31, 2021 06:34PM
Icon agoracom Valeo Pharma Reports its First Quarter 2021 Results and Highlights

0
AGORACOM
Mar 31, 2021 06:34PM
AGORACOM - Mar 31, 2021 11:41AM
Icon agoracom AGORACOM Small Cap 60: How Big Is Valeo Pharma’s Commercialization and Supply Agreement With Novartis?

0
AGORACOM
Mar 31, 2021 11:41AM
dfgkjkqa - Mar 30, 2021 05:41AM
https://sites.google...

0
dfgkjkqa
Mar 30, 2021 05:41AM
AGORACOM - Mar 29, 2021 05:28PM
Icon agoracom VIDEO – Valeo Pharma $VPH $VPHIF Enters Commercialization and Supply Agreement With Novartis To Address the $700M/ Year CDN Asthma Medication Market

0
AGORACOM
Mar 29, 2021 05:28PM
AGORACOM - Mar 29, 2021 02:33PM
Icon agoracom TRADING ALERT: Valeo Pharma (VPH: CSE) (VPHIF:OTCQB) Up 16% On 956K Shares

0
AGORACOM
Mar 29, 2021 02:33PM
AGORACOM - Mar 29, 2021 11:54AM
Icon agoracom INTERVIEW ALERT: @valeo_pharma $VPH.ca

0
AGORACOM
Mar 29, 2021 11:54AM
AGORACOM - Mar 29, 2021 10:51AM
Icon agoracom IIROC Trade Resumption - VPH

0
AGORACOM
Mar 29, 2021 10:51AM
AGORACOM - Mar 29, 2021 10:41AM
Icon agoracom Valeo Pharma Inc. Enters into an Agreement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Canada

0
AGORACOM
Mar 29, 2021 10:41AM
AGORACOM - Mar 26, 2021 02:15PM
Icon agoracom Valeo Pharma to Report First Quarter 2021 Results and Hold Investors Conference Call / Webcast

0
AGORACOM
Mar 26, 2021 02:15PM
AGORACOM - Mar 11, 2021 02:18PM
Icon agoracom CLIENT FEATURE: Valeo Pharma (VPH: CSE) An Innovative Canadian Pharma Company With 9 Products Currently Marketed And 7 Products In Pipeline

0
AGORACOM
Mar 11, 2021 02:18PM
AGORACOM - Mar 04, 2021 10:15AM
Icon agoracom CLIENT FEATURE: Valeo Pharma (VPH: CSE) An Innovative Canadian Pharma Company With 9 Products Currently Marketed And 7 Products In Pipeline

0
AGORACOM
Mar 04, 2021 10:15AM
AGORACOM - Mar 01, 2021 02:37PM
Icon agoracom INDUSTRY BULLETIN: Global Citrus Bioflavonoids Market Is Expected to Reach USD 5.65 Billion by 2028

0
AGORACOM
Mar 01, 2021 02:37PM
New Message